Abstract
Background
Zinc deficiency has been identified as an important factor contributing to chronic nutritional disorders in maintenance hemodialysis (HD) patients.
Aim
We assessed the long-term effect of zinc replacement therapy on all-cause mortality among patients undergoing HD.
Methods
This posthoc analysis utilized data from an open-label, multicenter, randomized, active-controlled study including HD patients aged 40–94 years, registered between December 2019 and May 2020. Patients who initiated zinc supplementation were categorized into two groups based on treatment status 12 months after initiation: continuation (n = 46) and discontinuation (n = 22). The primary outcome was 4-year all-cause mortality. Survival was compared by Kaplan–Meier analysis, and hazard ratios (HRs) were estimated using Cox proportional hazards models.
Summary
The 4-year survival rate was higher in the continuation group (54.8%) than in the discontinuation group (33.9%, log-rank P = 0.122). Continuation of zinc therapy significantly reduced mortality risk (HR: 0.33, 95% CI: 0.11–0.95, P = 0.041). Independent predictors of mortality included age (HR: 1.09 per year), female sex (HR: 2.46), primary kidney disease (HR: 2.81), serum albumin <3.5 g/dL (HR: 4.35), transthyretin <20 mg/dL (HR: 3.59), and phosphorus <3.7 mg/dL (HR: 3.28). Subgroup analysis revealed that albumin ≥3.5 g/dL was protective in the continuation group, while malnutrition and inflammation markers were strongly associated with mortality in the discontinuation group. Continuation of zinc replacement therapy was associated with significantly improved survival in HD patients. These findings suggest that sustained supplementation may provide prognostic benefit, particularly in those with preserved nutritional status.
Registration
The study was registered with the University Hospital Medical Information Network (UMIN) under registration number 000038759.
Get full access to this article
View all access options for this article.
References
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
